no youll have to google fda anda review cycle and read up to understand what im talking about basically the fda has 6 months from the time they begin their review of the application to make a response jan 2015 in fluticare case if they deny it for any reason and the co fixes the issue and resubmits it then the fda has another 6 months to respond this can go back and forth until the fda finally approves it or sends a complete response letter or clr a clr generally kills the submission and that is when most bios pr the info and the stock tanks so im saying cos generally dont pr that they got a response from fda unless it is an end result response of either approval or clr legitimate cos would offer an explanation of some kind to shareholders after 30 months but innv just does some other side deal
Don't argue with an Idiot! He'll drag you down to his level and beat you with experience.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.